Development and Evaluation of a Prediction Model for Underestimated Invasive Breast Cancer in Women with Ductal Carcinoma In Situ at Stereotactic Large Core Needle Biopsy

被引:14
|
作者
Diepstraten, Suzanne C. E. [1 ]
van de Ven, Stephanie M. W. Y. [2 ]
Pijnappel, Ruud M. [1 ]
Peeters, Petra H. M. [3 ]
van den Bosch, Maurice A. A. J. [1 ]
Verkooijen, Helena M. [1 ]
Elias, Sjoerd G. [3 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands
[2] Stanford Univ, Med Ctr, Dept Radiol, Stanford, CA 94305 USA
[3] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 10期
关键词
LYMPH-NODE BIOPSY; DIAGNOSIS; DISEASE; RISK; MICROCALCIFICATION; RECOMMENDATIONS; MANAGEMENT; IMPUTATION; SPECIMENS; LESIONS;
D O I
10.1371/journal.pone.0077826
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: We aimed to develop a multivariable model for prediction of underestimated invasiveness in women with ductal carcinoma in situ at stereotactic large core needle biopsy, that can be used to select patients for sentinel node biopsy at primary surgery. Methods: From the literature, we selected potential preoperative predictors of underestimated invasive breast cancer. Data of patients with nonpalpable breast lesions who were diagnosed with ductal carcinoma in situ at stereotactic large core needle biopsy, drawn from the prospective COBRA (Core Biopsy after RAdiological localization) and COBRA2000 cohort studies, were used to fit the multivariable model and assess its overall performance, discrimination, and calibration. Results: 348 women with large core needle biopsy-proven ductal carcinoma in situ were available for analysis. In 100 (28.7%) patients invasive carcinoma was found at subsequent surgery. Nine predictors were included in the model. In the multivariable analysis, the predictors with the strongest association were lesion size (OR 1.12 per cm, 95% CI 0.98-1.28), number of cores retrieved at biopsy (OR per core 0.87, 95% CI 0.75-1.01), presence of lobular cancerization (OR 5.29, 95% CI 1.25-26.77), and microinvasion (OR 3.75, 95% CI 1.42-9.87). The overall performance of the multivariable model was poor with an explained variation of 9% (Nagelkerke's R-2), mediocre discrimination with area under the receiver operating characteristic curve of 0.66 (95% confidence interval 0.58-0.73), and fairly good calibration. Conclusion: The evaluation of our multivariable prediction model in a large, clinically representative study population proves that routine clinical and pathological variables are not suitable to select patients with large core needle biopsy-proven ductal carcinoma in situ for sentinel node biopsy during primary surgery.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: Causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy
    Hoorntje, LE
    Schipper, MEI
    Peeters, PHA
    Bellot, F
    Storm, RK
    Rinkes, IHMB
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (07) : 748 - 753
  • [32] Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision
    Renshaw, Andrew A.
    Derhagopian, Robert P.
    Martinez, Pilar
    Gould, Edwin W.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (02) : 310 - 313
  • [33] Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ
    Meurs, Claudia J. C.
    van Bekkum, Sara
    van Rosmalen, Joost
    Menke-Pluijmers, Marian B. E.
    Siesling, Sabine
    Westenend, Pieter J. J.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7069 - 7080
  • [34] Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ
    Claudia J. C. Meurs
    Sara van Bekkum
    Joost van Rosmalen
    Marian B. E. Menke-Pluijmers
    Sabine Siesling
    Pieter J. Westenend
    Annals of Surgical Oncology, 2023, 30 : 7069 - 7080
  • [35] A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers
    Meurs, Claudia J. C.
    van Rosmalen, Joost
    Menke-Pluijmers, Marian B. E.
    ter Braak, Bert P. M.
    de Munck, Linda
    Siesling, Sabine
    Westenend, Pieter J.
    BRITISH JOURNAL OF CANCER, 2018, 119 (09) : 1155 - 1162
  • [36] A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers
    Claudia J. C. Meurs
    Joost van Rosmalen
    Marian B. E. Menke-Pluijmers
    Bert P. M. ter Braak
    Linda de Munck
    Sabine Siesling
    Pieter J. Westenend
    British Journal of Cancer, 2018, 119 : 1155 - 1162
  • [37] Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia
    Lin, PH
    Clyde, JC
    Bates, DM
    Garcia, JM
    Matsumoto, GH
    Girvin, GW
    AMERICAN JOURNAL OF SURGERY, 1998, 175 (05): : 380 - 382
  • [38] Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer
    Jang Yoo
    Bom Sahn Kim
    Hai-Jeon Yoon
    Annals of Nuclear Medicine, 2018, 32 : 328 - 336
  • [39] Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer
    Yoo, Jang
    Kim, Bom Sahn
    Yoon, Hai-Jeon
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (05) : 328 - 336
  • [40] Different Clinical and Pathologic Determinants Might be Possible to Predict Invasive Breast Cancer in Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy
    Altundag, Kadri
    JOURNAL OF ULTRASOUND IN MEDICINE, 2019, 38 (06) : 1649 - 1649